![]() |
|
|
-Opioid Receptor Gene
Department of Pharmacology, University of Minnesota, Minneapolis, Minnesota 55455
| |
Summary |
|---|
|
|
|---|
Dual promoters were identified in the mouse
-opioid receptor (KOR)
gene. The distal promoter was located in the 5
-upstream region of exon
1 and the proximal promoter was located in the first intron of this
gene. The transcription initiation site of the proximal promoter was
mapped to the
93rd nucleotide position from the ATG codon in a primer
extension experiment. The expression of KOR mRNAs transcribed from
these two promoters in mouse central nervous system and an embryonal
carcinoma cell line P19 was confirmed in a ribonuclease protection
assay. In non-neuronal tissues, only the transcripts initiated from the
distal promoter were detected. The biological activities of these two
promoters were determined in transient transfection of P19 cells with a
series of reporters, each truncated at various 5
-upstream regions. It
was concluded that the distal promoter was located between nucleotide
positions
990 and
570, and the proximal promoter was located
between nucleotide positions
330 and
93, relative to the
translation initiation codon. The presence of dual promoters in the KOR
gene suggested potential regulation of KOR expression by using
different promoters.
| |
Introduction |
|---|
|
|
|---|
Several
opioid receptor types are present in the central and peripheral nervous
systems, distinguished by their preference for different ligands (for
reviews, see Refs. 1 and 2). Autoradiographic and in situ
hybridization studies indicate that these opioid receptors and their
mRNAs can be found in brain and spinal cord areas that are involved in
pain sensation (for reviews, see Ref. 3 and 4). In addition to the
spatial specificity, the expression of these receptors also exhibits
temporal specificity, being differentially expressed in various
developmental stages. The
receptor binding sites can be detected as
early as gestation stage E14.5, followed by an increase during early
postnatal life and a gradual decline to the adult level (5). To study
how the expression of the
-opioid receptor gene is regulated for its
tissue and developmental specificity, we have previously isolated the
mouse gene, designated as KOR, and determined its entire genomic structure (6).
The mouse KOR gene spans a distance of approximate 16 kb and contains 4 exons. Based upon the DNA sequence of its 5
-upstream region, this gene
is characteristic of a housekeeping gene, containing multiple
transcription initiation sites but no TATA box sequences in the
5
-upstream region. By comparing its 5
-upstream sequence with a TFDB,
many potential regulatory DNA elements are located in this region.
Interestingly, the translation of KOR mRNA starts within the second
exon, and several clusters of potential regulatory elements are present
in the first exon and the first intron.
This report follows our previous study by characterizing two promoters and their upstream regulatory region of the mouse KOR gene. Specifically, three questions are addressed: 1) Can the first intron function as a promoter, and if yes, where is the transcription initiation site of this promoter? 2) Are the KOR mRNAs transcribed from the two promoters differentially expressed in mouse tissues? 3) Where are the two KOR promoters and what are their biological activities?
| |
Experimental Procedures |
|---|
|
|
|---|
Sequence of the 5
-regulatory region and promoter mapping.
DNA sequences of the 5
-upstream region were determined from a subclone
of the mouse KOR gene containing the 5
-upstream region using the
dideoxy nucleotide chain termination method (7). The second (proximal)
promoter was determined in a primer extension experiment using a
specific primer (P1, 5
-CTGGAAAGCGAGAAGGTG-3
; see Fig.
1 for its position) complementary to a
sequence in the intron. The procedure was as described previously (6).
|
Analyses of KOR mRNA expression.
RNA was isolated from mouse
tissues and cell lines as described previously (6). To detect different
KOR mRNA species, RPA was modified from a procedure established
previously (8), using an RPAII kit from Ambion (Austin, TX). To
differentiate KOR transcripts that were overlapping in the coding
region (beginning from exon 2), a DNA fragment of approximate 260 bp
was selected from a genomic segment containing a portion of intron 1 and exon 2 as indicated in Fig. 1. This genomic segment was inserted
into pSp73 (Promega, Madison, WI) for in vitro transcription
into riboprobes with T7 RNA polymerase. An actin cDNA vector was
provided in the kit for the synthesis of antisense riboprobes using SP6
RNA polymerase. Probes were labeled with
[
-32P]UTP and the full-length probes were
further purified from a polyacrylamide gel. For each RPA reaction, 30 µg of total RNA were incubated with 2 × 105 cpm probes at 45° overnight. After
hybridization, a mixture of RNase A and RNase T1 was added and
incubated at 37° for 30 min. The digested RNA was denatured in
boiling water and immediately separated in a denaturing 5%
polyacrylamide gel. A DNA marker was prepared by labeling
HpaII-digested pBR322 DNA with
[
-32P]dCTP.
Reporters for KOR promoter activities.
A reporter for the
KOR promoter activity was constructed by inserting the
Escherichia coli
-galactosidase (lacZ) structure gene
(pMC 1871; Pharmacia, Piscataway, NJ) into a KOR genomic clone, at the
14th bp position after the translation initiation codon ATG. This
construct generated an in-frame fusion gene that utilized the ATG codon
of KOR and included four additional amino-terminal amino acid residues
of the mouse KOR protein at the amino terminus of the lacZ protein.
This construct, designated as KOR-lacZ (
4590 construct), was used to
generate a series of deletion mutants truncated from the 5
end of the
KOR gene by digesting with appropriate restriction enzymes or ligating
the PCR-generated genomic fragments with the lacZ cassette. The
1320
construct was generated by BamHI deletion of the parental
construct and the
990 construct was generated by BglII
deletion of the parental construct. The
570,
330,
280, and
170
constructs were all made by ligating PCR-generated genomic fragments
into the lacZ cassette. The
570/del-Pr2 was made by ligating the
amino terminus of KOR cDNA (beginning at the
570 position) to the
lacZ cassette, thus deleting the entire intron 1.
Cell culture techniques and the determination of reporter
activities in cell lines.
P19 cells were maintained in
minimal
essential medium supplemented with 2.5% fetal calf serum and 7.5%
calf serum as described previously (9). CHO cells were maintained in
Dulbecco's modified Eagle's medium supplemented with 10% fetal
bovine serum as described elsewhere (10). The calcium phosphate
precipitation method (9) was used for transfections. Cells were
transfected with each reporter DNA at equal molecular ratio, and
cytosolic extracts were collected at 24 hr after transfection to
determine lacZ activities. The lacZ activities were determined using a
solution assay as described previously (9) and represented as
A420/105 cells. As an
internal control, a ptK-luc vector was included in each transfection
experiment. This luciferase reporter has been shown to be expressed at
a constant basal level in P19 cells (9). Luciferase activities were
determined using a luciferase assay kit from Promega (Madison, WI) and
represented as arbitrary luciferase units. The specific lacZ activity
was represented as A420/arbitrary
luciferase unit for each reporter.
| |
Results |
|---|
|
|
|---|
Dual promoters of the mouse KOR gene.
In our previous study
(6), we identified three major transcription initiation sites of the
mouse KOR gene, approximately 200-500 bp upstream from the 5
end of
the mouse KOR cDNA. We later detected a different KOR mRNA species, in
a RT-PCR, which was transcribed from the first intron of this gene. To
validate this novel species of KOR transcript, we conducted primer
extension experiments using a primer (P1) complementary to the first
intron to examine RNA isolated from both mouse brain and a mouse cell line, P19, which expressed the KOR gene. The expression of this novel
transcript in mouse tissues was further confirmed in RPA (see the
following). Fig. 1A showed the KOR genomic region where the relative
position of the P1 primer used in primer extension, as well as the
probe and the protected fragments in RPA experiments, was indicated.
The sizes of the probes and the protected fragments in RPA were
indicated on the right. Fig. 1B shows the DNA sequence spanning exon 1, intron 1, and exon 2, from which the riboprobe (Fig. 1B,
underlined) was prepared. The first base in each protected fragment was indicated with an asterisk (*).
93rd nucleotide
upstream from the translation initiation codon ATG. For a negative
control, yeast tRNA (Fig. 2, lane Y) was included in the
experiment. Based upon this result and the results of our previous
study (6), it was concluded that the mouse KOR gene utilized two
promoters, one located in the 5
upstream of the first exon and the
other located within the first intron.
|
Differential expression of two types of KOR mRNAs in mouse tissues and P19 cells. The size of KOR message expressed in mouse brain was estimated to be approximately 6 kb based upon Northern blot analysis in our previous study (6). Later, we also detected the expression of KOR mRNA in Northern blots, approximately 6 kb in length, in a mouse embryonal carcinoma cell line P19 (data not shown). Because the sizes of KOR mRNAs transcribed from these two promoters were too close to be distinguished in a typical Northern blot analysis, we established an RPA that allowed different types of KOR transcripts to be differentiated in the same reaction. By using riboprobes prepared from a genomic DNA segment as indicated in Fig. 1, three types of KOR transcripts were detected in this type of RPA. The first type was transcribed from the distal promoter and spliced at the 14th nucleotide upstream from the initiating ATG codon of exon 2 (transcript 1), the second type was transcribed from the same distal promoter but spliced at the 30th nucleotide upstream from the first splicing junction (transcript 2) and the third type was transcribed from the proximal promoter located in intron 1 (transcript 3). The band protected by transcript 1 was 139 (fragment d) bp in length because only the sequence transcribed from exon 2 could be protected. The band protected by transcript 2 was 169 bp (fragment c) in length because 30 additional bases were protected. The band protected by transcript 3 was 218 bp (fragment b) in length, covering 79 bp from intron 1 and 139 bp from exon 2. For an internal control, actin probes were hybridized with each sample and a band of approximate 250 bp (fragment a) was expected. Fig. 3 shows a typical result of differential KOR mRNA expression detected in the RPA. Three major protected bands of approximately 218, 169, and 139 bp in size (Fig. 3, b, c, and d, respectively) were detected in P19, brain, and spinal cord (Fig. 3, lanes 6, 7, and 8, respectively) samples. A relatively constant level of actin expression (fragment a) was detected in all the samples (Fig. 3, lanes 12-17). Using a PhosphorImager to quantify the densities of these bands, the ratio of b/c/d was estimated to be approximately 1/2/10 for these three samples. Thus, it was concluded that the distal promoter was much stronger than the proximal promoter because the transcripts initiated from the distal promoter, represented by the 139- and 169-bp bands, were approximately 12-fold more abundant than the transcripts initiated from the proximal promoter represented by the 218-bp band.
|
The determination of dual KOR promoter activities. To determine the biological activities of the two promoters, the series of lacZ reporters were transiently co-transfected into P19 and CHO cells with an internal control luciferase vector. The lacZ activity of each reporter was normalized to the internal control for transfection efficiency, and represented as the specific lacZ activity as described in Experimental Procedures. The amount of DNA used in each transfection was carefully determined based upon the molecular size of each construct, so that each relative reporter activity was presented as the specific activity from an equal number of molecules for all the constructs. The results were obtained from four independent experiments, each conducted with duplicate cultures, to determine the means and standard errors of the means (mean ± standard error).
As shown in Fig. 4B, the shortest reporter that still retained the proximal promoter activity was the
330 construct, whereas deletion for another 50 bp (
280 construct)
or 160 bp (
170 construct) resulted in the complete loss of reporter
activity in P19. Addition of 250 bp more (exon 1 and a portion of
intron 1) to the
330 construct generated the
570 construct, which
contained the entire KOR cDNA sequence. Addition of the first exon
sequence alone (
570) appeared to have no effects on this proximal
promoter, whereas a further extension to the
990 position, which
covered two of the three transcription initiation sites of the distal
promoter, stimulated the reporter activity by approximately 50%. In
the construct containing additional 330-bp sequence (the
1320
construct), the reporter activity increased for another 50%, which is
approximately 2-fold the proximal promoter activity. Interestingly, the
reporter activity decreased to about the basal proximal promoter (the
320 construct) activity in the longest construct, which contained approximately 4.6 kb of the 5
-upstream region (the
4590 construct). In addition, deletion of the proximal promoter from the
570
construct, the
570/del.Pr2 construct, abolished all the reporter
activity, confirming the biological activity of promoter 2 encoded in
this intron. All of these reporters were also transfected into CHO cells, and none of these reporters expressed lacZ activity, indicating that the lacZ activities detected in P19 cells were specific to the KOR
gene. From the reporter activities of these deletion mutants, it was
concluded that the proximal promoter of the KOR gene was located
between nucleotide positions
93 and
330, with the sequence between
280 and
330 positions encoding the essential biological activity
for this promoter. The distal promoter was located between nucleotide
positions
570 and
990. The sequence between positions
990 and
1320 encoded some stimulatory activity whereas the sequence 5
to the
1320 position encoded a slightly suppressive activity.
|
| |
Discussion |
|---|
|
|
|---|
We isolated several overlapping genomic clones covering the entire
mouse KOR gene, and identified a major promoter located in the
5
-upstream region of exon 1 in a previous study (6). In this study,
KOR mRNA initiated from a promoter located in intron 1 was first
detected in RT-PCR experiments (data not shown) and the transcription
initiation of this new RNA species was located, in a primer extension
experiment, to the
93rd nucleotide position with respect to the ATG
codon. The expression of transcripts initiated from the two promoters
was further confirmed in RPA experiments. P19 and all the major mouse
organs were examined to determine differential expression of these KOR
transcripts. It appeared that KOR transcripts initiated from the distal
promoter could be spliced at two different positions 30 bp apart,
generating two types of mRNAs (represented by protected band
c and d in RPA). KOR transcription could also
initiate from the proximal promoter, resulting in the mRNA species
represented by the protected band b in the RPA. All three
types of mRNAs were detected in P19, mouse brain, and spinal cord, but
only the transcript represented by band d was detected in
non-CNS tissues such as the stomach. In addition, mRNAs represented by
band d appeared to constitute the major KOR mRNAs in either
mouse CNS tissues or the P19 cell line. Thus, it was concluded that
promoter 1 (the distal promoter) was the primary promoter for KOR
expression in both CNS and non-CNS tissues. In contrast, promoter 2 (the proximal promoter) encoded a much weaker activity and appeared to
be active only in the CNS. As expected, KOR expression, from either the
proximal or the distal promoter, was strongest in the CNS.
Based upon the signals from PhosphorImager analyses of the protected fragments, the ratio of the mRNAs initiated from the distal promoter (represented by bands c and d) to the mRNAs initiated from the proximal promoter (represented by band b) was estimated to be approximately 12 to 1 in P19 and mouse CNS. By studying a lacZ reporter gene and its deletion mutants in P19 cells, the biological activities of these two promoters were confirmed and the positions of these two promoters were located. However, the distal promoter was only approximately 2-fold stronger than the proximal promoter based upon this type of reporter analysis. It is possible that some regulatory information for the distal promoter may be missing in the constructs. Alternatively, the dissected proximal promoter activity as detected by transient transfection experiments could be stronger than its physiological activity as a result of deleting some regulatory sequences from the genomic locus or the accumulation of transient reporter activity in transfected cells. Finally, it is also possible that mRNA stability varies among the different types of KOR transcripts. The reporter activities may not reflect mRNA stability, which could vary among the three types of transcripts.
The activity of two promoters used by the KOR gene was confirmed, based
upon the expression of endogenous KOR mRNA from these two promoters and
the reporter assays. Addition of exon 1 sequence to the proximal
promoter had no effects on the proximal promoter, suggesting that no
regulatory information was encoded within exon 1 sequence (the
570
construct) in the P19 system. Deletion of promoter 2 from the
570
construct abolished its promoter activity, confirming the activity of
promoter 2 located inside the intron. Addition of the sequence
containing two of the three transcription initiation sites of the
distal promoter increased the reporter activity (the
990 construct),
confirming the distal promoter (promoter 1) activity encoded between
nucleotide positions
570 and
990. Addition of another 330 bp (the
1320 construct, containing another transcription initiation site of
the distal promoter) increased the reporter activity to the highest
level, which was approximately 2-fold of the proximal promoter activity
(the
320 construct), based upon the transient transfection
experiments. Interestingly, the addition of the entire 4.6 kb of the
5
-upstream region suppressed the reporter activity to about the basal
proximal promoter activity. Thus, the sequence 5
to the
1320
position probably contained some negative regulatory activity for this gene. However, it remains to be determined if this slightly suppressive activity is transferable and if more regulatory sequences are present
in the further upstream sequence.
By comparing this series of reporter activities, it was concluded that
the distal and the proximal promoters were located between nucleotide
positions
570 and
990 and between positions
93 and
330,
respectively. The differential use of dual promoters and the presence
of an untranslated exon in the 5
region of the coding sequence in KOR
gene raised an interesting issue about its regulation. Three major KOR
mRNA isoforms were detected, including the major RNA species as shown
in the first cloned cDNA (11, 12) that spans the 4 exons, an isoform
containing a 30-nucleotide insert derived from intron 1 as detected in
mouse R1.1 cells (13) and P19 (this study), and another isoform
transcribed from a promoter located in intron 1 (this study). Based
upon the genomic sequence, it was shown that a rat KOR isoform (14)
could be transcribed from intron 1 sequence, starting at a region
further upstream from the proximal promoter identified in this study.
However, using RT-PCR, we could not detect additional mouse KOR
transcripts initiated from the region corresponding to this particular
rat initiation site (data not shown).
KOR expression could be detected not only in nervous system, but also in some immune cell types by more sensitive assays such as RT-PCR (15, 16). We detected KOR expression in the stomach in RPA, suggesting that KOR neurons were present in this organ in relatively high levels. By RT-PCR analysis, we also detected some KOR expression in other organs such as the heart (data not shown). KOR expression in these non-CNS tissues was mostly from the distal promoter, indicating that the proximal promoter was probably CNS-specific. Utilization of alternative promoters to generate mRNA isoforms that can be differentially regulated has been widely observed in the nuclear hormone receptor gene families (17). It has also been observed in several membrane receptor genes more recently, such as the human D1A dopamine receptor gene (18) and the human A1 adenosine receptor gene (19). This study has demonstrated, for the first time, the specific sequence requirement and the biological activities of the two KOR promoters in mouse tissues and cell lines. However, it remains to be answered as to the physiological significance of the use of alternative promoters for the KOR gene and differential regulation of these two KOR promoters.
Within the 5
-untranscribed region of the distal promoter, no typical
TATA or CAAT boxes were present, but multiple initiation sites of
transcription were identified (6). In addition, many putative
transcription factor binding sites were found in this sequence as
compared with the TFDB, such as NF-µE1, GATA, NF-IL6, granulocyte/macrophage-colony stimulating factor, glucocorticoid response element, and SP-1. Interestingly, the proximal promoter used a
single transcription initiation site, although it contained no TATA
box. By comparing with the TFDB, several putative transcription factor
binding sites were also found in the upstream region of the proximal
promoter, such as heat shock factor and a zinc finger-type transcription factor Adr1. However, the authenticity of these regulatory elements and their biological functions await further studies. This study unambiguously demonstrated different expression levels of the KOR mRNAs transcribed from two promoters in mouse tissues
and P19 cell line and the biological activities of the two KOR
promoters. These findings raised interesting questions about KOR gene
expression with respect to alternate promoter usage and differential
regulation in various tissues.
| |
Acknowledgments |
|---|
We thank Dr. L. Chang for help in enzyme assays and P19 cultures. We thank the core B of a program project DA08131 for providing the oligonucleotides.
| |
Footnotes |
|---|
Received February 20, 1996; Accepted May 8, 1997
This study was supported by National Institutes of Health Grants DA01583, DA05695, K05-70554, and the F & A Stark Fund of Minnesota Medical Foundation (H.H.L.) and DK46866 and MMF-975-95 (L.N.W.)
Send reprint requests to: Dr. Li-Na Wei, Department of Pharmacology, University of Minnesota Medical School, 3-249 Millard Hall, 435 Delaware Street S.E., Minneapolis, MN 55455. E-mail: weixx009{at}maroon.tc.umn.edu
| |
Abbreviations |
|---|
KOR,
-opioid receptor;
TFDB, transcription factor database;
RPA, ribonuclease protection assay;
CNS, central nervous system;
PCR, polymerase chain reaction;
CHO, Chinese
hamster ovary;
RT, reverse transcription;
bp, base pair;
kb, kilobase
pair.
| |
References |
|---|
|
|
|---|
| 1. | Goldstein, A. and A. Naidu. Multiple opioid receptors: ligand selectivity profiles and binding signatures. Mol. Pharmacol. 36:265-272 (1989)[Abstract]. |
| 2. | Loh, H. H. and A. P. Smith. Molecular characterization of opioid receptors. Annu. Rev. Pharmacol. Toxicol. 30:123-147 (1990)[Medline]. |
| 3. | Mansour, A., C. A. Fox, H. Akil, and S. J. Watson. Opioid receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 18:22-29 (1995)[Medline]. |
| 4. | Elde, R., U. Arvidsson, M. Riedl, L. Vulchanova, J. H. Lee, R. Dado, A. Nakano, S. Chakrabarti, X. Zhang, and H. H. Loh. Distribution of neuropeptide receptors. New views of peptidergic neurotransmission made possible by antibodies to opioid receptors. Ann. N. Y. Acad. Sci. 757:390-404 (1995)[Abstract]. |
| 5. | Kitchen, I., M. Kelly, and P. M. Viveros. Ontogenesis of kappa opioid receptors in rat brain using 3H-U69593 as a binding ligand. Eur. J. Pharmacol. 175:93-96 (1990)[Medline]. |
| 6. |
Liu, H.-C.,
S. Lu,
L. B. Augustin,
R. F. Felsheim,
H.-C. Chen,
H. H. Loh, and
L.-N. Wei.
Cloning and promoter mapping of mouse opioid receptor gene.
Biochem. Biophys. Res. Commun.
209:639-647 (1995)[Medline].
|
| 7. |
Sanger, F.,
S. Nicklen, and
A. R. Coulson.
DNA sequencing with chain-terminating inhibitors.
Proc. Natl. Acad. Sci. USA
74:5463-5467 (1977) |
| 8. | Wei, L.-N, W. S. Blaner, D. S. Goodman, and M. C. Nguyen-Huu. Regulation of the cellular retinoid-binding proteins and their messenger ribonucleic acids during P19 embryonal carcinoma cell differentiation induced by retinoic acid. Mol. Endocrinol. 3:454-463 (1989)[Abstract]. |
| 9. |
Wei, L.-N. and
L. Chang.
Promoter and upstream regulatory activities of the mouse cellular retinoic acid binding protein-I gene.
J. Biol. Chem.
271:5073-5078 (1996) |
| 10. | Maggio, R. Sodium nitroprusside induces internalization of muscarinic receptors stably expressed in Chinese hamster ovary cell lines. J. Neurochem. 65:943-946 (1995)[Medline]. |
| 11. |
Chen, Y.,
A. Mestek,
J. Liu, and
L. Yu.
Molecular cloning of a rat opioid receptor reveals sequence similarities to the µ and opioid receptors.
Biochem. J.
295:625-628 (1993).
|
| 12. |
Li, S.,
J. Zhu,
C. Chen,
Y. W. Chen,
J. K. Deriel,
B. Ashby, and
L. Y. Liu-Chen.
Molecular cloning and expression of a rat opioid receptor.
Biochem. J.
295:629-633 (1993).
|
| 13. |
Belkowski, S. M.,
J. Zhu,
L. Y. Liu-Chen,
T. K. Eisenstein,
M. W. Adler, and
T. J. Rogers.
Sequence of opioid receptor cDNA in the R1.1 thymoma cell line.
J. Neuroimmunol.
62:113-117 (1995)[Medline].
|
| 14. |
Yakovlev, A. G.,
K. Krueger, and
A. I. S. Faden.
Structure and expression of a rat opioid receptor gene.
J. Biol. Chem.
270:6421-6424 (1995) |
| 15. | Lawrence, D. M. P. and J. M. Bidlack. Kappa opioid binding sites on the R1.1 murine lymphoma cell lines: sensitivity to cations and guanine nucleotides. J. Neuroimmunol. 41:223-230 (1992)[Medline]. |
| 16. |
Belkowski, S. M.,
J. Zhu,
L. Y. Liu-Chen,
T. K. Eisenstein,
M. W. Adler, and
T. J. Rogers.
Detection of opioid receptor mRNA in immature T cells.
Adv. Exp. Med. Biol.
373:11-16 (1995)[Medline].
|
| 17. | Mangelsdorf, D. J., K. Umesono, and R. M. Evans. The retinoid receptors, in The Retinoids (M. B. Sporn, A. B. Roberts and G. S. Goodman, eds.). Raven Press, New York, 319-350 (1993). |
| 18. |
Lee, S.-H.,
M. T. Minowa, and
M. M. Mouradian.
Two distinct promoters drive transcription of the human D1A dopamine receptor gene.
J. Biol. Chem.
271:25292-25299 (1996) |
| 19. | Ren, H. and G. L. Stiles. Separate promoters in the human A1 adenosine receptor gene direct the synthesis of distinct messenger RNAs that regulate receptor abundance. Mol. Pharmacol. 48:975-980 (1995)[Abstract]. |
This article has been cited by other articles:
![]() |
J. Li, S. W. Park, H. H. Loh, and L.-N. Wei Induction of the Mouse kappa -Opioid Receptor Gene by Retinoic Acid in P19 Cells J. Biol. Chem., October 11, 2002; 277(42): 39967 - 39972. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Hu, J. Bi, H. H. Loh, and L.-N. Wei Regulation of Mouse kappa Opioid Receptor Gene Expression by Different 3'-Untranslated Regions and the Effect of Retinoic Acid Mol. Pharmacol., October 1, 2002; 62(4): 881 - 887. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Park, J. Li, H. H. Loh, and L.-N. Wei A Novel Signaling Pathway of Nitric Oxide on Transcriptional Regulation of Mouse kappa Opioid Receptor Gene J. Neurosci., September 15, 2002; 22(18): 7941 - 7947. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bi, X. Hu, H. H. Loh, and L.-N. Wei Regulation of Mouse {kappa} Opioid Receptor Gene Expression by Retinoids J. Neurosci., March 1, 2001; 21(5): 1590 - 1599. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-N. Wei, X. Hu, J. Bi, and H. Loh Post-Transcriptional Regulation of Mouse kappa -Opioid Receptor Expression Mol. Pharmacol., February 1, 2000; 57(2): 401 - 408. [Abstract] [Full Text] |
||||
![]() |
X. Hu, J. Bi, H. H. Loh, and L.-N. Wei An Intronic Ikaros-binding Element Mediates Retinoic Acid Suppression of the Kappa Opioid Receptor Gene, Accompanied by Histone Deacetylation on the Promoters J. Biol. Chem., February 9, 2001; 276(7): 4597 - 4603. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||